Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ASBP
- Price
- 1.81
- Stock movement down
- -0.10 (-5.24%)
- Company name
- Aspire BioPharma, Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 6.26M
- Ent value
- 18.19M
- Price/Sales
- 3227.56
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ASBP does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3227.56 |
| Price to Book | - |
| EV to Sales | 9369.82 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.46M |
| EPS (TTM) | -25.64 |
| FCF per share (TTM) | -2.84 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.94K |
| Gross profit (TTM) | 884.00 |
| Operating income (TTM) | -20.02M |
| Net income (TTM) | -31.74M |
| EPS (TTM) | -25.64 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 45.54% |
| Operating margin (TTM) | -214748.36% |
| Profit margin (TTM) | -214748.36% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.95M |
| Net receivables | 0.00 |
| Total current assets | 2.40M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 2.40M |
| Accounts payable | 1.06M |
| Short/Current long term debt | 8.62M |
| Total current liabilities | 13.86M |
| Total liabilities | 13.87M |
| Shareholder's equity | -11.47M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -3.52M |
| Capital expenditures (TTM) | 4.00 |
| Free cash flow (TTM) | -3.52M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -1320.75% |
| Return on Invested Capital | 1116.58% |
| Cash Return on Invested Capital | 123.70% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.01 |
| Daily high | 2.02 |
| Daily low | 1.71 |
| Daily Volume | 1.50M |
| All-time high | 17.80 |
| 1y analyst estimate | - |
| Beta | 0.87 |
| EPS (TTM) | -25.64 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ASBP | S&P500 | |
| Current price drop from All-time high | -89.83% | -0.89% |
| Highest price drop | -89.83% | -19.00% |
| Date of highest drop | 22 Jan 2026 | 8 Apr 2025 |
| Avg drop from high | -54.04% | -2.49% |
| Avg time to new high | 21 days | 6 days |
| Max time to new high | 59 days | 89 days |
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
6.26M
Marketcap category
Small-cap
Description
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner